Monday, September 11, 2017

Gritstone Oncology Gets $92.7M

Emeryville-based Gritstone Oncology, a cancer immunotherapy startup focused on personalized medicine for treating patients with non-small cell lung cancer and gastric cancer, said last week that it raised $92.7M in a Series B funding round. The funding was led by Lilly Asia Ventures, and also included GV (formerly Google Ventures), Trinitas Capital (Beijing) and Alexandria Venture Investments, along with Versant Ventures, The Column Group, Clarus Funds and Frazier Healthcare Partners. More information »